Erysipelas;Erisipela

Acta Medica Portuguesa

Volumn 18, Issue 5, 2005, Pages 385-394

  Caetano, Mónica ^a   Amorim, Isabel ^a  

^a HOSPITAL DE SANTO ANTÓNIO   (Portugal)

Author keywords

Dermo hypodermic infections; Diagnosis; Erysipelas; Prevention; Treatment

Indexed keywords

AMOXICILLIN; AMPICILLIN; ANTICOAGULANT AGENT; BENZATHINE PENICILLIN; CEFAZOLIN; CEFRADINE; CEFTRIAXONE; CIPROFLOXACIN; CLARITHROMYCIN; CLINDAMYCIN; CORTICOSTEROID; ERYTHROMYCIN; FLUCLOXACILLIN; IMIPENEM; LINEZOLID; NEW DRUG; NONSTEROID ANTIINFLAMMATORY AGENT; PENICILLIN DERIVATIVE; PENICILLIN G; VANCOMYCIN;

BACTERIUM CULTURE; CLINICAL FEATURE; ERYSIPELAS; FEVER; HISTOPATHOLOGY; HUMAN; INFECTION RISK; INFLAMMATION; LEUKOCYTOSIS; LYMPHADENOPATHY; LYMPHANGITIS; LYMPHEDEMA; NECROTIZING FASCIITIS; NUCLEAR MAGNETIC RESONANCE IMAGING; OBESITY; PHARMACODYNAMICS; REVIEW; RISK FACTOR; SKIN INFECTION; STREPTOCOCCUS GROUP A; VEIN THROMBOSIS;

ANTI-BACTERIAL AGENTS; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; ANTICOAGULANTS; ERYSIPELAS;

EID: 32044449650     PISSN: None     EISSN: 16460758     Source Type: Journal    
DOI: None     Document Type: Review

References (33)

1. GROSSHAN E: Erysipelas: Clinicopathological classification and terminology. Ann Dermatol Venereol 2001; 128: 128:307-11.
2. BONNETBLANC JM, BEDANE C: Erysipelas: recognition and management. Am J Clin Dermatol 2003; 4(3):157-63.
3. BERNARD P, BEDANE C, MOUNIER M, DENIS F, BONNETBLANC JM: Bacterial dermo-hypodermatitis in adults. Incidence and role of streptococcal etiology. Ann Dermatol Venereol 1995; 122:495-500.
4. DUPUY A: Descriptive epidemiology and knowledge of erysipelas risk factors. Ann Dermatol Venereol 2001; 128:312-16.
5. BISNO AL, STEVENS D: Streptococcal infections of skin and soft tissues. N Engl J Med 1996; 334:240-5.
6. VAILLANT L: Diagnostic criteria for erysipelas. Ann Dermatol Venereol 2001; 128:326-33.
7. DENIS F, MARTIN C, PLOY MC: Erysipelas: microbiological and pathogenic data. Ann Dermatol Venereol 2001; 128:317-25.
8. SWARTZ MN: Cellulitis. N Engl J Med 2004; 350:904-12.
9. DUPUY A, BENCHIKHI H, ROUJEAU JC et al: Risk factors for erysipelas of the leg (cellulitis): case control study. Br Med J 1999; 318:1591-4.
10. GIVNER LB: Periorbital versus orbital cellulitis. Pediatr Infect Dis J. 2002; 21:1157-8.
11. ESTINES O, COSTE N, PERCEAU G, BECKER S, LEBERRUYER P-Y, BENARD P: Haemorrhagic cellulitis: three cases. Ann Dermatol Venereol 2003; 130(5):523-6.
12. STONE DR, GORBACH SL: Necrotizing Fasciitis. The Changing Spectrum. In Sadick NS, ed. Infectious diseases in Dermatology. Dermatol Clin 1997; 15(2):213-20.
13. ROUJEAU JC: Necrotizing cellulites and fasciitis: clinical criteria and risk factors. Ann Dermatol Venereol 2001; 128:376-81.
14. WONG CH, KKHIN LW, HENG KS, TAN KC, LOW CO. The LRINEC (laboratory risk indicator for necrotizing fasciitis) score: a tool for distinguishing necrotizing fasciitis from other soft tissue infections. Crit Care Med 2004; 32(7):1535-41.
15. WALL DB, KLEIN SR, BLACK S, DE VIRGILIO C. A simple model to help distinguish necrotizing fasciitis from nonnecrotizing soft tissue infection. J Am Coll Surg 2000; 191(3):227-31.
16. BARIE PS. The laboratory risk indicator for necrotizing fasciitis (LRINEC) score: useful tool or paralysis by analysis? 2004; 32(7):1618-9.
17. DESCHAMPS V, LEJOYEUX F, MARCK Y, BOUSCARAT F, CRICKX B, BELAICH S: Erysipelas-like mercury exanthem. Contact Dermatitis 1997; 36:277-8.
18. LUCHT F: Which treatment for erysipelas? Antibiotic treatment: drugs and methods of administering. Ann Dermatol Venereol 2001; 128:345-7.
19. PERL B, GOTTEHRER NP, RAVEH D, SCHLESINGER Y, RUDENSKY B, YNNON AM: Cost-effectiveness of blood cultures for adult patients with cellulites. Clin Infect Dis 1999; 29(6):1483-8.
20. SACHS MK: The optimum use of needle aspiration in the bacteriologic diagnosis of cellulitis in adults. Arch Intern Med 1990; 150:1907-12.
21. BERNARD P, BEDANE C, MOUNIER M, DENIS F, CATANZANO G, BONNETBLANC JM: Streptococcal cause of erysipelas and cellulitis in adults. A microbial study using a direct immunofluorescence technique. Arch Dermatol 1989; 125:779-82.
22. BERNARD P, TOTY L, MOUNIER M, DENIS F, BONNETBLANC JM: Early detection of streptococcal group antigens in skin samples by latex particle agglutination. Arch Dermatol 1987; 123(4):468-70.
23. LEPPARD BJ, SEAL DV, COLMAN G, HALLAS G: The value of bacteriology and serology in the diagnosis of cellulitis and erysipelas. Br J Dermatol 1985; 112(5):559-67.
24. PERROT JL, PERROT S, LAPORTE SIMITSIDIS S: Is anticoagulant therapy useful when treating erysipelas? Ann Dermatol Venereol 2001; 128(3 Pt 2):352-7.
25. SCHMID MR, KOSSMAN T, DUEWELL S: Differentiation of necrotizing fasciitis and cellulites using MRI imaging. Am J Roentgenol 1998; 170:615-20.
26. GUBERMAN D, GILEAD LT, ZLOTOGORSKI A, SCHAMROTH J: Bullous erysipelas: A retrospective study of 26 patients. J Am Acad Dermatol 1999; 41(5):733-737.
27. GAUZIT R: Contribution of linezolid to the treatment of complicated infections of the skin and soft tissues. Presse Med. 2003; 32(13 Pt 2):S17-20.
28. CHOSIDOW O, SAIAG P, PINQUIER L, BASTUJI-GARIN S, REVUZ J, ROUJEAU JC: Nonsteroidal anti-inflammatory drugs in cellulitis: a cautionary note. Arch Dermatol 1991; 127:1845-6.
29. HOLDER EP, MOORE PT, BROWNE BA: Nonsteroidal anti-inflammatory drugs and necrotising fasciitis. Drug Saf 1997; 17:369-73.
30. CRICKX C: Erysipelas: evolution under treatment, complications. Ann Dermatol Venereol 2001; 128:358-62.
31. HUGO-PERSON M, NORLIN K: Erysipelas and group G streptococci. Infection. 1987; 15:184-7
32. CRICKX B, CHEVRON F, SIGAL-NAHUM M et al: Erysipelas: epidemiological, clinical and therapeutic data (111 cases). Ann Dermatol Venereol. 1991; 118(1):11-6.
33. WANG JH, LIU YC, CHENG DL et al: Role of benzathine penicillin G in prophylaxis for recurrent streptococcal cellulitis of the lower legs. Clin Infect Dis. 1997; 25(3):685-9.